Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2013
Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with menSara Gianella, Davey M Smith, Milenka V Vargas, et al.AIDS (London, England)|July 4, 2006
Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578)Glenn J Wagner, David E Kanouse, Daniela Golinelli, et al.AIDS (London, England)|May 7, 2009
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatmentRichard H Haubrich, Sharon A Riddler, A Gregory DiRienzo, et al.Journal of Virology|May 3, 2014
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatmentSara Gianella, Marta Massanella, Douglas D Richman, et al.Annals of Internal Medicine|November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled TrialKaren T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.Scientific Reports|August 25, 2015
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral TherapyMarta Massanella, Sara Gianella, Rachel Schrier, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 6, 2007
A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patientsBrookie M Best, Miguel Goicoechea, Mallory D Witt, et al.AIDS (London, England)|July 16, 2019
Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimenGiuliano Rizzardini, Andrea Gori, Celia Miralles, et al.Plos One|January 30, 2020
HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimensGregory D Huhn, Moti Ramgopal, Mamta K Jain, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2014
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapyChad J Achenbach, Ashley L Buchanan, Stephen R Cole, et al.Pageof 4